CHARLESTOWN, Mass. — August 28, 2025 — Leads & Copy — Solid Biosciences Inc. (Nasdaq: SLDB) will participate in several investor conferences in September 2025, including the Citi Biopharma Back to School Conference, Cantor Global Healthcare Conference, H.C. Wainwright 27th Annual Global Investment Conference, and the Baird Global Healthcare Conference.
Bo Cumbo, President and CEO, will participate in fireside chats at each conference. Live webcasts will be available for each chat on the Events page of the Investors section of the Company website. Webcast replays will be archived for 90 days.
Solid Biosciences is focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases. The company is also developing innovative libraries of genetic regulators and other enabling technologies with promising potential to significantly impact gene therapy delivery cross-industry.
Solid Biosciences Investor Contact:
Nicole Anderson
Director, Investor Relations and Corporate Communications
Solid Biosciences Inc.
investors@solidbio.com
Media Contact:
Glenn Silver
FINN Partners
glenn.silver@finnpartners.com
Source: Solid Biosciences
